Sioris L J, Weibert R T, Pentel P R
Arch Intern Med. 1980 Apr;140(4):546-7.
The prothrombin time (PT) of a patient undergoing warfarin sodium anticoagulation became elevated when sulfisoxazole was given concurrently. The warfarin dose index is used to demonstrate that this PT prolongation was the result of a warfarin-sulfisoxazole interaction. The mechanism of this interaction may involve displacement of warfarin from serum albumin. Sulfisoxazole should be used cautiously, if at all, in patients taking warfarin.
在接受华法林钠抗凝治疗的患者中,同时给予磺胺异恶唑时,其凝血酶原时间(PT)升高。使用华法林剂量指数来证明这种PT延长是华法林与磺胺异恶唑相互作用的结果。这种相互作用的机制可能涉及华法林从血清白蛋白上的置换。服用华法林的患者应谨慎使用磺胺异恶唑(若要使用则需极其谨慎)。